Australia's most trusted
source of pharma news
Saturday, 12 July 2025
Posted 1 October 2024 AM
Bayer, Johnson & Johnson, Organon, Pfizer, and UCB have each welcomed PBS listings for their drugs this month with one company scooping a triple win.
Pfizer's once-daily oral treatment for ulcerative colitis Velsipity has been added to the scheme for the first time.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.